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Abstract 
Background: Patient engagement in clinical practice guideline (CPG) development has increased significantly in recent 
years. However, only a few patients and caregivers join CPG development groups. 
Objective: To describe participant experiences with a novel online, scalable approach for patient and caregiver engagement 
in CPG development.  
Design: We developed and tested the RAND/PPMD Patient-Centeredness Method (RPM), a novel online modified-Delphi 
approach to patient engagement in CPG development that consists of an optional idea generation round and two rating 
rounds interspersed with an online discussion round. 
Setting and Participants: Using the online ExpertLens™ system, we ran 2 concurrent panels of patients and caregivers of  
individuals with Duchenne Muscular Dystrophy (DMD). 
Main Outcome Measures: We surveyed all 95 panel participants about their participation and satisfaction with the process. 
We also conducted telephone interviews with 25 participants.  
Results: Participants expressed satisfaction with various ExpertLens™ features, noting that the system fostered lively 
interaction among them. Panelists also appreciated participating in an educational, interactive and convenient discussion 
forum that allowed them to share their opinions on the importance and acceptability of different recommendations. The 
RPM was viewed as empowering by patients and their caregivers who felt it would be useful for CPG developers. 
Discussion and Conclusion: The results of our study show the overall participant satisfaction with a novel, scalable, online 
approach to engaging patients and caregivers in CPG development, which allows them to share their perspectives and lived 
experiences using a rigorous, systematic and iterative way that is similar to how clinicians provide their input. 
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Clinical practice guidelines (CPGs) are systematically 
developed to provide guidance on appropriate healthcare 
options for various medical conditions [1]. A key 
component of the quality of these clinical 
recommendations is the composition of the guideline 
development group (GDG) [2-4]. GDGs, however, have 
historically struggled to engage patients in this process. 





While clinicians contribute clinical expertise, patients and 
caregivers share their judgements, concerns, values and 
preferences on clinical processes based on their lived 
experience of a particular disease or condition [5]. 
Including patients and their caregivers throughout the 
stages of CPG development may help frame how patients 
view and think about clinical recommendations and may 
lead to the development of guidelines that are potentially 
more likely to be accepted by them [6]. Therefore, it is 
important that patients and their caregivers are involved in 
CPG development to ensure that they are patient-centered 
and to increase guideline adherence. 
Increased interest in patient and caregiver engagement 
in the CPG development process has mobilized efforts to 
identify systematic methods for engaging these stakeholder 
groups [7,8]. However, due to limited budget and logistical 
constraints, the absence of patients in guideline 
development is common [1]. When engaged, only a few 
patient representatives are typically included in the CPG 
development process [9,10]. Additionally, patient 
representation primarily involves in-person engagement at 
guideline meetings [8], which can be particularly 
restrictive for patients with limited mobility. As a result, 
there have been calls to explore online methods as a 
promising way to include a wide array of patients and 
patient representatives in CPG development in a systematic 
and scalable way [11]. However, little is known about 
patients’ and caregivers’ online engagement experiences 
[11].  
The objective of this study is to describe the 
experiences of patients and caregivers who tested the 
RAND/PPMD Patient-Centeredness Method (RPM) - a 
new online approach to patient engagement in CPG 
development [12]. Our study assesses patient and caregiver 
views on the usefulness of, their satisfaction with, and the 
challenges that they encountered while participating in the 
online engagement process that mirrors the approach 
clinicians used to develop the 2018 Duchenne Muscular 





Case Study  
 
DMD is a progressively fatal neuromuscular disorder that 
affects approximately 1 in 5,000 boys [15]. The effects of 
this rare disease include muscle weakness, loss of 
ambulation and premature death by the mid-to-late second 
decade of life. In 2010, the US Centers for Disease Control 
and Prevention (CDC) developed DMD care 
considerations to help healthcare providers and Duchenne 
families better manage this rare disease [16,17]. Care 
considerations were revised in 2018 to include new 
evidence [13]. Clinical experts used a consensus method 
known as the RAND/UCLA Appropriateness Method 
(RAM), which involves reviewing existing evidence and 
rating the clinical appropriateness and necessity of 
different treatments or care management options [18]. 
Patients were not involved in the development of many 
sections of the 2018 DMD care considerations.  
To address this gap, we developed the RPM - an online 
modified-Delphi approach for incorporating patient and 
caregiver input in the CPG development process. To test 
the RPM, we engaged individuals with DMD and their 
caregivers using ExpertLens™ - a previously-evaluated 
online modified-Delphi platform for expert elicitation and 
stakeholder engagement [19-21]. Participants were not 
required to travel to a centralized location, but rather 
shared their perspectives from the comfort of their home, 
which was particularly useful for DMD families for whom 
travel is challenging. While ExpertLens™ was not used to 
develop the CDC guidelines, we based our online approach 
on the modified-Delphi method and the RAM that 




To identify individuals with DMD and their caregivers, we 
used the Parent Project Muscular Dystrophy’s (PPMD) 
Duchenne Registry. In February 2017, we sent recruitment 
emails to 719 potential participants and asked them to 
express their interest in our study by answering a series of 
demographic questions. Out of 153 individuals interested 
in our study, we invited 122 individuals to participate. We 
excluded those who participated in our pilot study, parents 
and children providing the same email address and 
caregivers from the same household. Informed consent was 
provided to all participants prior to the start of the study 
and RAND’s Human Subjects Protection Committee 
(HSPC) determined this study was exempt.  
 
The RAND/PPMD Patient-Centeredness 
Method  
 
The RPM is a three-round modified-Delphi process that 
can consist of 3 or 4 rounds [11] and that could be 
implemented using ExpertLens™. In Round 0, which is 
optional in the RPM, a separate, smaller sample of 
individuals with DMD and their caregivers provided input 
on the reasons for, barriers to, and facilitators of seeking 
care for various aspects of DMD.1 In Round 1, individuals 
with DMD and their caregivers reviewed information 
about, rated and explained their perspectives on 19 care 
considerations. Specifically, they used 9-point Likert 
scales to rate the importance and acceptability of each care 
consideration for a typical DMD family. The RPM 
considers importance and acceptability of guideline 
recommendation to be key dimensions of patient-
centeredness. In Round 2, participants saw bar charts that 
showed the distribution of group’s responses, described 
how their Round 1 responses (presented as red dots on the 
charts) compared to those of other participants and stated 
whether the group reached agreement on the importance or 
acceptability of a given care consideration determined 
using the RAM’s approach to measuring consensus [18].  
                                                          
1 Round 0 participants were not included in the sample described 
in this article. 
Armstrong, Grant, Kinnett, Denger, Martin, Coulter, Booth & 
Khodyakov 
 




Table 1  Participant Characteristics 
 
 Participated in 
at least one 
round  (n=95) 
Participated in 
Round 1  
(n=88) 
Participated in 
Round 2  
(n=74) 
Participated in 
Round 3 (n=56) 
Participant Type     
Caregiver 71 (75%) 65 (74%) 58 (78%) 43 (77%) 
Individual with DMD 24 (25%) 23 (26%) 16 (22%) 13 (23%) 
     
Gender     
Female 59 (62%) 53 (60%) 47 (64%) 35 (63%) 
Male 36 (38%) 35 (40%) 27 (36%) 21 (37%) 
     
Hispanic/Latino/Spanish*     
Yes 4 (4%) 2 (2%) 3 (4%) 1 (2%) 
No 90 (95%) 85 (97%) 70 (95%) 54 (96%) 
     
Race     
White 86 (91%) 82 (93%) 67 (91%) 52 (93%) 
Black/African American 1 (1%) 1 (1%) 1 (1%) 0 (0%) 
Asian 4 (4%) 3 (3%) 4 (5%) 4 (7%) 
Multi-race 1 (1%) 0 (0%) 1 (1%) 0 (0%) 
Other 3 (3%) 2 (2%) 1 (1%) 0 (0%) 
     
How far do you usually travel to 
receive neuromuscular care?* 
    
<50 miles 38 (40%) 37 (42%) 30 (41%) 25 (45%) 
50-99 miles 22 (23%) 20 (23%) 16 (22%) 12 (21%) 
100-249 miles 17 (18%) 13 (14%) 14 (19%) 8 (14%) 
≥250 miles 15 (16%) 15 (17%) 13 (18%) 9 (16%) 
Notes: * Not all participants provided responses to this question. There were no statistically significant 
differences between participants and non-participants in different rounds as measured by Fisher’s exact test 
[23]. 
 
Each question from Round 1 had its own chart and a 
summary of participant comments. In this round, 
participants also discussed Round 1 results using 
asynchronous and online discussion boards moderated by 3 
trained professionals (a caregiver, a genetic counselor and 
a modified-Delphi expert). Participation in the discussion 
was partially anonymous: we used IDs that only revealed 
whether a participant was an individual with DMD or a 
caregiver/family member. 
To encourage active engagement during discussion, 
participants received periodic discussion digests via email. 
Lastly, in Round 3, participants had the opportunity to 
revise their original ratings based on Round 2 feedback and 
discussion of Round 1 results. Additional information on 
study design [22] and patient-centeredness ratings [23] can 
be found elsewhere. 
 
Assessment of Participant Experiences  
 
To assess participant experiences with the RPM, we used a 
mixed-methods evaluation approach. We surveyed all 
Round 1 and Round 3 participants and conducted 
telephone interviews with a purposive sample of 
participants at the end of the modified-Delphi process. 
Participants used a 7-point Likert scale (1 = strongly 
disagree, 2 = disagree, 3 = slightly disagree, 4 = neutral, 
5 = slightly agree, 6 = agree, 7 = strongly agree) to rate 
statements describing different aspects/features of the 
online modified-Delphi process (see Table 2). The 
majority of these statements are based on research on 
computer-mediated communication and have been used in 
previous ExpertLens™ panels [20,21].  
After the entire process finished, we selected a diverse 
sample of 5 patients and 20 caregivers for semi-structured 
telephone interviews to further share their experiences and 
thoughts about the RPM. We stratified our interview 
sample based on participant type (patient or caregiver), 
their level of engagement and participation in each round 
and their level of satisfaction with the online engagement 
process. The study team developed semi-structured 
interview questions that covered several topics about 
participants’ experiences: overall participation burden, 
advantages of the iterative Delphi process relative to a 
simple survey, perceived level of engagement in the 
discussion round, benefits and challenges of online 
discussion and overall usefulness of the RPM for 
patient/caregiver engagement in the process of CPG 
development. Interviews ranged from 30 to 45 minutes. 
Study participants received a $50 Amazon.com gift card 
for successful completion of each study round, for a total 





We conducted descriptive analyses of responses to 
satisfaction questions. As in previous studies of participant 
experiences with the ExpertLens™ process [20,21], we 
considered a mean of ≥5 on positively worded statements 
regarding   different   aspects / features   of   the   online  






Table 2 Survey Results about Participant Experiences with the Online Modified-Delphi Approach 
 
Rating Statements 
Total Individuals with DMD Caregivers P value 
M SD N M SD n M SD n  
The topic of this study is important 6.49 0.64 54 6.67 0.65 12 6.44 0.64 42 0.282 
The invitation text was clear 6.18 1.42 77 6.37 1.50 19 6.12 1.40 58 0.510 
The login instructions were clear 6.44 1.07 77 6.82 0.39 19 6.31 1.18 58 0.008 
The rating scales used in this study are clear 6.05 1.19 77 6.05 1.61 19 6.05 1.03 58 0.100 
The charts in Round 2 were clear 5.81 1.25 52 6.33 0.78 12 5.65 1.33 40 0.098 
The charts helped me understand how my responses 
compared to those of other participants 6.1 1.19 52 6.75 0.45 12 5.90 1.27 58 0.001 
The ExpertLens™ system is easy to use 5.35 1.64 54 5.08 1.44 12 5.43 1.71 42 0.533 
I would like to use ExpertLens™ in the future 5.34 1.58 54 5.00 1.60 12 5.44 1.58 42 0.403 
Participation in this study was satisfying 5.61 1.27 54 5.83 1.19 12 5.55 1.29 42 0.500 
The study will generate useful outcomes 6.04 0.97 54 6.08 1.16 12 6.02 0.92 42 0.853 
The discussion was informative 5.92 1.16 52 5.75 1.14 12 5.97 1.18 40 0.564 
I was comfortable sharing my views 6.33 0.79 52 6.42 0.90 12 6.30 0.76 40 0.656 
Notes: Participants were asked to use 7-point Likert-type response scales, where, 1 = strongly disagree, 2 = disagree, 3 = slightly disagree, 
4 = neutral, 5 = slightly agree, 6 = agree, 7 = strongly agree, to indicate the extent to which they agreed with each of the statements 
presented in this table. The sample sizes differ because participants were asked to rate different statements after different study rounds. 
 
engagement process to be an indicator of a “positive” or 
“favorable” experience. We rounded the mean values to 
the nearest whole number. We also used t-tests to 
determine the existence of statistically significant 
differences between patient and caregiver experiences.  
To qualitatively analyze the interview data, we 
developed a code book based on the interview guide and 
coded the telephone interview data using MaxQDA, a 
computer-assisted qualitative data analysis software [24]. 
CA (an experienced qualitative researcher) coded all 
qualitative data, which were then reviewed  by  DK  (the 
principal investigator of the study who is an expert on 
qualitative and Delphi methodologies, stakeholder and 
patient engagement and the ExpertLens™ approach). CA 
and DK developed the code book together and discussed 
any disagreements about the way it was applied to the 
interview data until consensus was achieved. A similar 
process was used in previous studies [25]. Finally, we used 
an inductive thematic approach to qualitative data analysis 
to jointly identify emergent themes about participants’ 
experiences in the RPM, satisfaction with the data 
collection process, online engagement process and 
usefulness of the ExpertLens™ platform and the online 





Out of 122 invited participants, 95 (78%) participated in at 
least one modified-Delphi round. Of these, 88 (93%) 
participated in Round 1; 74 (78%) participated in Round 2 
and 56 (59%) participated in Round 3. Seventy-seven 
Round 1 participants (88%) and 54 Round 3 participants 
(96%) answered a series of questions regarding their 
satisfaction with the ExpertLens™ process. 
The majority of study participants were caregivers 
(75%); most were female (62%) and white (91%). Forty 
percent of study participants reported living within a 50-
mile radius from a clinic where individuals with DMD 
receive neuromuscular care. There were no statistically 
significant differences in demographic characteristics of 
those who participated and those who did not participate in 
different rounds based on the results of the Fisher’s exact 
test (see Table 1) [23].  
The results section is structured thematically around 5 
main themes describing participant experiences and 
perceived usefulness of our online approach to engaging 
patients and caregivers in CPG development that we 
developed based on the analysis of survey and interview 
data. We describe each of these themes below by using 
both survey and interview data and provide additional 
illustrative quotations in an online appendix (see Appendix 
A). To protect participant confidentiality, we used codes 
that only revealed whether they are individuals with DMD 
or caregiver, as well as their panel (A or B). 
 
Perceived Importance of the Study and 
Comprehension of the Tasks 
 
Study participants thought that the study topic was 
important, understood the reasons why it was conducted 
and felt that they understood how the data would be 
collected. To illustrate, those who completed a survey 
agreed that the study topic was important (M=6.49; 
SD=0.64, see Table 2). Our interviewees also reported that 
they fully understood the objective of the study. As 
caregiver A10 explained, the study purpose was to:  
 
“get a better idea of the priorities of patients and 
caregivers and … how we would respond to certain 
recommendations” (Caregiver A10).  
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From the perspective of an individual with DMD A01:  
 
“the purpose of the study was to get both patient and 
family input on new proposed clinical guidelines with 
the goal of providing more efficient and better care for 
those with DMD” (Individual A01).  
 
At first, however, some participants did not fully 
understand the purpose of the study. Nonetheless, even 
those initially confused understood the data collection 
process as they progressed through study rounds. 
According to caregiver B12:  
 
“Initially, I didn’t really know what the point was, but as 
it went along, I kind of figured out what was going on” 
(Caregiver B12). 
 
Despite the uniqueness and novelty of our data 
collection process, participants generally reported high 
levels of understanding the logistics of participation in our 
study. In their responses to survey questions, participants 
agreed that the invitation text (M=6.18, SD=1.42), login 
instructions (M=6.44, SD=1.07) and rating scales 
(M=6.05, SD=1.19) were clear. Individuals with DMD 
reported somewhat better understanding of login 
instructions than caregivers (M=6.82 vs. M=6.31, p=0.008, 
respectively).  
In Round 2, participants saw Round 1 results presented 
in a chart format. Overall, they had positive attitudes 
towards the charts. Survey participants agreed that the 
charts were clear and easy to understand (M=5.81, 
SD=1.25) and that charts helped them understand how 
their responses compared to those of other participants 
(M=6.1, SD=1.19). It is worth noting that, compared to 
caregivers, patients were more likely to have a more 
favorable opinion about the usefulness of Round 2 charts 
in helping them understand the difference between their 
own and other participants’ responses (M=5.9, SD=1.27 
and M=6.75, SD=0.45, p=0.001, respectively).  
Most of our interviewees also expressed a positive 
opinion about the charts, suggesting that they help 
participants quickly understand what the group thinks. As 
caregiver B05 put it:  
 
“The charts are beneficial just to have a visual look of 
where your answer falls and where the rest of the group 
went with their answer. It is important to have it. It 
allows for a glance into what other people were 
thinking” (Caregiver B06).  
 
An individual with DMD B06 also agreed on the 
benefits of having charts:  
 
“The charts are easy to understand because it’s a visual, 
so it's easy to see. Seeing how my answers compared to 
others made me kind of want to look more in the 
discussions to see why” (Individual with DMD B06).  
 
Nonetheless, a very small number of caregivers 
indicated that while they understood the charts, they:  
 
“found it a little hard to find my original response” on 
the chart (Caregiver A04).  
 
Benefits of Online Engagement Using 
ExpertLens™ 
 
Survey participants generally had positive online 
experiences: they reported that ExpertLens™ was easy to 
use (M=5.35; SD=1.64) and that they would like to use the 
platform again in the future (M=5.34; SD=1.58). Our 
interviewees discussed multiple benefits of using the 
online modified-Delphi platform for the purposes of 
soliciting patient and caregiver input, as compared to 
surveys and in-person meetings. Within the broad theme of 
benefits, participants emphasized 3 aspects of the 
ExpertLens™ process that they particularly enjoyed, 
including the interactive nature, anonymity and 
convenience.  
Overall, participants enjoyed the interactive nature of 
the process that included feedback loops and opportunities 
to directly engage with and learn from other participants. 
The iterative nature of data collection fostered better 
participant engagement by increasing their willingness to 
share and discuss their opinions and experiences with 
others, resulting in the development of new and shared 
perspectives. According to caregiver A01, ExpertLens™ 
gave individuals:  
 
“an opportunity to see where you are, in terms of other 
parents and patients, and what things they are discussing 
that you may not be thinking about” (Caregiver A01).  
 
The ability to gain new insights from engaging with 
others in a similar predicament was highly regarded as a 
benefit by caregiver B02 who said:  
 
“I really did appreciate what other people were writing 
about, and I learned a lot by just reading the other 
responses” (Caregiver B02).    
 
Participants also appreciated the partial anonymity of 
Round 2 because they felt that it gave them a sense of 
comfort and security during the discussion. Participants 
commented on the usefulness of the labels that were used 
during the discussion round to denote comments made by 
different participants, and how these labels helped them 
understand different perspectives without divulging too 
much personal information:  
 
“I like the ability to not put a face or a name on the 
person, just a number. And that way if there was major 
disagreement you could still speak your mind” 
(Caregiver B03). 
  
While participants generally found the label to be 
sufficient and useful, some recommended adding a 
participant profile with the patient’s age, region and 
disease stage while still keeping participant’s name 
anonymous. As noted by individual with DMD A01, the 
use of the labels:  
 





“reinforced, in my mind, that not only do I have to think 
about my perspective as a patient, but of the caregiver 
perspective, as well” (Individual with DMD A01). 
 
Finally, compared to in-person meetings, participants 
found the online engagement process to be a very 
convenient way of participating in research, particularly 
given physical, geographic and time constraints Duchenne 
families face. To illustrate, individual with DMD A02 said:  
 
“I think it’s just a more convenient way of doing it, 
considering that most people find it difficult to get out of 
the house. It was more convenient for me, instead of 
going somewhere” (Individual with DMD A02). 
  
The convenience of an online approach was amplified 
by the asynchronous nature of the engagement process. 
Participants found the engagement process accommodating 
given that they could complete each round at their 
convenience rather than finishing all of it in one sitting. As 
individual with DMD B01 put it:  
 
“[the engagement process] is set up nicely so that I can 
come in and do one of the sections at a time. I knew I 
could start one and get through maybe one of them and 
then come back at a later time to tackle each of the other 
ones, in turn” (Individual with DMD B01). 
 
Satisfaction with the RPM 
 
Survey participants agreed that their participation in this 
study that tested the RPM was satisfying (M=5.61; 
SD=1.27). By analyzing the interview data, we identified 4 
factors that have contributed to participants’ overall high 
satisfaction of the engagement process.  
First, the engagement of both caregivers and patients 
stimulated discussion of the importance of the patient 
perspective. Participants overwhelmingly agreed that the 
adult patients’ voice carried more weight than the 
caregiver/parent perspective when rating many 
recommendations, especially if caregivers were new to a 
Duchenne diagnosis, did not have much experience or 
knowledge of the disease progression, or even when a 
parent had a son who was too young to make decisions on 
their own. As caregiver B01 noted:  
 
“It was definitely very helpful to hear what the patient is 
feeling rather than what I feel as a parent, which is pretty 
helpful because I want to do what’s important for my 
son even though he’s not old enough right now” 
(Caregiver B01).  
 
Moreover, patients agreed that the parent/caregiver 
perspective can be limited when making certain clinical 
decisions:  
 
“my parents absolutely want the best for me, it’s just 
they don’t necessarily exactly understand how I feel.” 
(Individual with DMD A03). 
 
Second, the RPM offered patients a unique opportunity 
to serve as the experts and share their knowledge and 
experiences directly with caregivers:  
 
“There’s a lot of things that [caregivers] aren’t being 
prepared for, so I was able to tell them that certain things 
may not be as easy as people might think” (Individual 
with DMD A02).  
 
As pointed out by individual with DMD B04, the 
opinions and perspectives of caregivers, and especially 
patients, are not considered during the CPG development 
process. This emphasizes the need for a process to 
incorporate the patient voice in care decision-making and 
guideline development. 
Third, participants enjoyed learning new information 
and new perspectives from other DMD families. As 
explained by caregiver B05, participants were able to gain 
more insight from others who have had a lot more 
experience with DMD:  
 
“The hope is that you learned something from reading 
other people's comments or at the least gives you a point 
of view into somebody else's world of possibility. And 
that may not benefit you immediately, but at least in the 
future you can keep that in the back of your mind” 
(Caregiver B05).  
 
Others reported gaining a better understanding of the 
disease phases based on their review of discussion 
comments and considered their participation a unique 
learning opportunity. This was particularly important for 
parents of younger boys who have yet to encounter a 
specific disease stage. 
Finally, the Delphi-based RPM allowed participants to 
change their original responses, if they wished to do so, but 
did not require them to reach consensus. There were 2 
broad perspectives on the topic of revising original 
responses. Some participants appreciated the ability to 
change their responses. To use the words of caregiver B06:  
 
“I actually did like revising my answers. After reading 
everyone’s situations and different opinions, I learned 
more about [different topics], so I was able to tweak my 
answers because it made me feel differently” (Caregiver 
B06).  
 
Many caregivers reported that their opinions and 
ratings changed after seeing patients’ ratings and 
comments. Caregiver B06 explained how thinking about 
height was not initially considered important:  
 
“but for some, it was a big deal because they are non-
ambulatory and that makes a big difference when your 
peers are all towering over you when you’re standing, as 
opposed to when you’re sitting. So those kinds of 
answers, I did change a little because it was quite clear a 
lot of people thought that was important” (Caregiver 
B06). 
 
Others, however, reported that while their reasoning 
and understanding of issues broadened and they were:  
 
“exposed to a new way of thinking, the [rating] answers 
never really changed that much” (Individual with DMD 
A02).  
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Some pointed out that they were already well-versed 
and knowledgeable about the disease and did not feel 
pressure to change their answers just to conform, which 
highlights the importance of not requiring participants to 
change answers or to reach consensus. Caregiver B07 
stated that while the new perspective was appreciated, not 
much changed in Round 3:  
 
“I liked the fact that we shared answers with others and 
we were able to go back, re-evaluate and see what others 
thought and then revisit your answer. So, although I 
pretty much stayed the same on my answer, I did 
reevaluate and assess it” (Caregiver B07). 
 
Perceived Usefulness and Impact of the 
RPM 
 
Survey participants agreed that this study would generate 
useful outcomes (M=6.04; SD=0.97). The RPM may be 
useful for engaging patients and their caregivers in CPG 
development because it facilitates sharing of opinions, 
perspectives and experiences. Our participants noted that 
because DMD is a rare disease, doctors may not see many 
patients with this condition, which may create variability 
and inconsistencies in recommendations and treatment 
options offered to patients. As such, the RPM created a 
forum for Duchenne families to share information, 
exchange perspectives, discuss experiences and debate 
recommendations, which is:  
 
“super important, especially with muscular dystrophy, 
just because we really don’t know a ton about it,” 
(Caregiver A08). 
 
By asking patients and caregivers to rate the 
importance and acceptability of care recommendations, the 
RPM provided a helpful format for soliciting the patient 
and caregiver perspectives during CPG development. As a 
caregiver A09 put it:  
 
“It’s really important to engage patients and their 
caregivers. I believe that only they have the firsthand 
experience and they can share their important insight. 
Because they are dealing with everyday life, they are 
facing challenges and they are creative. They are so 
creative that they are finding solutions to how to 
overcome the challenges” (Caregiver A09). 
  
The RPM also helped empower patients and caregivers 
by allowing them to apply some of the new information 
during the patient-clinician encounter. According to 
caregiver B10, participation in the online panel was useful 
during a recent provider visit because it:  
 
“brought up questions that I didn’t even know to ask. It 
brought up topics that I wasn’t aware of. It empowered 
me. It gave me a little bit of a say in what’s going on. It 
made me feel better that the parents’ perspective is being 
taken and that they’re looking into these different areas, 
which is kind of cool” (Caregiver B10). 
 
Participants also commented on the usefulness of the 
method for clinicians, suggesting that doctors could benefit 
from patient and caregiver input to support the current 
standards and recommendations. It was argued that until 
the Duchenne guidelines are universally followed by all 
the neuromuscular centers around the country, physicians 
should consider the patient and caregiver voice, which can 
be solicited using this engagement method:  
 
“Once the guidelines are developed this way, they’re 
going to be pretty useful for clinicians. It will really help 
them understand what really matters most and is 
important for the community,” (Caregiver A01).  
 
Challenges with the ExpertLens™ Process 
and Suggestions for Improving the RPM 
 
Although participants were overall satisfied with the 
ExpertLens™ process, some offered several suggestions 
for improving the participant experience. Participants 
generally understood the purpose and benefits of 
answering the same questions twice. However, in Round 3, 
some suggested that showing not only their own Round 1 
responses to the rating questions on the charts, but also 
their own rationale comments right below the charts might 
be helpful.2 Doing so could help participants add to or 
modify their original rationale comments: 
 
“It was difficult to determine what my initial rationale 
comment was. I think it would have been better if I 
could have somehow seen what all my answers were in 
that category [of rationale comments] in Round 1” 
(Caregiver B06). 
 
Although participants agreed that the Round 2 
discussion was informative (M=5.92; SD=1.16) and that 
they were comfortable sharing their views (M=6.33; 
SD=0.79), a few participants felt there could have been 
more clarity in the instructions about what to expect from 
the modified-Delphi process, especially from Round 2 
discussions. Some individuals did not fully understand 
whether it was necessary to review all Round 2 comments 
related to a single rating question: 
 
“The instructions weren’t exactly clear as to whether 
you have to respond to each one, just a few, or the ones 
you disliked or liked” (Caregiver B04).  
 
They suggested to make the intent clearer in the 
instructions. 
Participants also offered additional suggestions around 
the email digests and their layout. While several 
participants found the email digests to be useful, they felt 
that the digests could be improved by embedding web links 
directly into the email digest to instantly connect users to 
updated comments and/or responses.  
Others commented on the organization and layout of 
the different rounds. As caregiver B11 put it:  
 
                                                          
2 In Round 2, participants saw their rationale comments, but they 
were not listed right next to the charts. 





“visually, I had to really focus to make sure I finished 
the page and that I clicked on each thing to make sure I 
could see all the responses” (Caregiver B11).  
 
Caregiver B12 added:  
 
“eventually I figured it out, but I would have liked it to 
be a little better organized so that you could see what 
people’s responses are and how the threads were 
organized” (Caregiver B12). 
 
Finally, a few participants felt that there were ways to 
decrease participation burden without comprising the 
integrity and value of responses. Caregiver A10 suggested 
having each participant focus on just one topic:  
 
“It would be interesting if you picked just one topic, like 
either weight or height. Then, on days one and two, you 
put your comments in. On days three and four, you read 
through [the comments], and then on days five and six, 





Little rigorous empirical evidence exists on engaging 
patients and caregivers in CPG development and their 
attitudes and perceptions of engagement processes [26]. 
Our research not only developed and evaluated the RPM - 
a novel, online, scalable method that solicited feedback on 
the importance and acceptability of the CPG - but also 
assessed patients’ and caregivers’ attitudes towards and 
their perceptions of the method. Our findings contribute to 
a limited body of evidence on the usefulness of online 
methods that include patient and caregiver perspectives 
and user satisfaction [11]. Additionally, our research 
addresses the lack of evidence involving patients with rare 
diseases in CPG development [5].  
We found that participants overwhelmingly reported 
positive experiences with the RPM, citing the convenience, 
anonymity and asynchronous nature of online engagement. 
This finding further supports evidence that online 
engagement methods may facilitate more openness from 
patients and their families [7], allowing them to be more 
comfortable to agree or dissent with others’ opinions. 
Participation convenience is critical for engaging patients 
with limited mobility and time constraints. Providing 
individuals with DMD and their caregivers an opportunity 
to share their insights in a manner that did not require 
travel or face-to-face engagement allowed for a more 
convenient way of sharing input and data gathering.  
Moreover, our study participants also appreciated input 
provided by individuals with Duchenne and gave more 
weight to their perspectives due to their lived experiences 
of the disease. This demonstrates the importance of 
soliciting patient perspectives, particularly within the 
Duchenne community, where caregivers often make 
crucial treatment decisions on behalf of their young 
children. Additionally, the information and insight 
gathered from participating in such an engagement process 
could be immediately useful during medical visits.  
Lastly, ExpertLens™ offered a platform for 
implementing the RPM that is not only useful for guideline 
developement, but also for the patient and caregiver 
community engagement more broadly. Participants 
reported that the method encouraged learning and 
community-building through the interative rounds. For 
individuals impacted by Duchenne and other rare diseases, 
the online modified-Delphi process can elevate the patient 
and caregiver voice in CPG development while 
simultaneously creating a sense of community among busy 
individuals who are located in different parts of the country 
or around the world.  
We note several limitations to our study. Because this 
is a case study focused on only one test of the RPM, it may 
not be generalizable beyond our sample or limited to the 
Duchenne community. More research is needed to 
understand whether the specific nature of this rare 
condition allows participants to be more engaged than 
others. Second, not all invited study participants completed 
the study and we interviewed only a sub-sample of 
participants. Although our 78% study participation rate 
compares favorably with other online Delphi studies, our 
results are limited to the perspectives of those who 
completed the survey or the interview. Lastly, not all 
interview data were double coded. To increase the rigor of 
the analysis, the code books were developed jointly by the 
interviewers, the coder and the study PI. Moreover, the 
study PI reviewed all coding results and discussed any 





Our online modified-Delphi engagement approach called 
the PRM and the ExpertLens™ platform offer a useful 
novel opportunity for patients and caregivers to participate 
in CPG development by providing their perspectives and 
lived experiences using a rigorous, systematic and iterative 
approach that is similar to how clinicians provide their 
input. Participants appreciated the ExpertLens™ features 
that fostered lively interaction and expressed their 
satisfaction with engaging in an educational, interactive 
and convenient forum that allowed them to share their 
opinions on the importance and acceptability of clinically 
appropriate and necessary care considerations. Lastly, the 
RPM could inform CPG development committees and 
could help determine the importance and acceptability of 
various recommendations, which are key components of 
the GRADE (Grading of Recommendations Assessment, 
Development and Evaluation) Evidence to Decision 
Framework [27].  
We note several areas for future research. While the 
majority of participants comprehended the tasks for each 
round, some initially found the instructions confusing, 
which could be attributed to the uniqueness of the iterative 
and interactive nature of the modified-Delphi process. This 
finding is consistent with evidence showing that online 
methods for engaging patients may require additional intial 
training on how to complete the required tasks [28]. More 
research is needed to better understand how best to address 
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the challenges participants face when completing online 
engagement approaches. Furthermore, future studies 
should demonstrate the added value of engaging patients in 
CPG development using the RPM. One objective metric 
could be guideline adherence.  
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1. PERCEIVED IMPORTANCE OF THE STUDY AND COMPREHENSION OF THE TASKS 
Participants Understood the 
Objective of the Study 
• “It felt to me that the purpose was to help adjust and set guidelines or recommendations for 
different treatment for Duchenne. Like they just wanted to get input from patients and clients, to 
better inform people about the disease” (Individual with DMD A2). 
 
• “I kind of thought the purpose was trying to find out what the patients and caregivers think is 
important, as far as the doctors go, what they’re concerned about” (Individual with DMD B12). 
 
• “Initially, I didn’t really know what the point was, but as it went along, I kind of figured out what 
was going on” (Caregiver B12).  
Positive Attitudes Towards the 
Charts 
• “I think the charts are beneficial just to have a visual look of where your answer falls and where 
the rest of the group went with their answer. I think it is important to have it.  It allows for a 
glance into what other people were thinking” (Individual with DMD B05). 
 
• “The charts are easy to understand because it’s a visual, so it's easy to see. Seeing how my 
answers compared to others made me kind of want to look more in the discussions to see why” 
(Individual with DMD B06). 
 
• “[The charts] made total sense and it was really nice to have so you could see what other people 
were thinking, as well, because there’s obviously no right or wrong answers” (Caregiver A42). 
 
• “The charts I think they're beneficial to have a visual look of where your answer falls, where the 
rest of the group went with their answer; whether it was a wide, solid mark or just you standing 
alone on Number 4 or Number 3 scale.  I think it is important to have it.  It allows for a glance” 
(Caregiver B19). 
•  
2. BENEFITS OF ONLINE ENGAGEMENT USING EXPERTLENS™ 
Interactive Nature of the Process • “I thought it was really good. I mean, there were some things that I didn’t think of from certain 
perspectives…like the patients were able to say - especially my son being 20 and having autism, 
he doesn’t have a lot of say simply because he’s just not capable of things that he may want to 
Armstrong, Grant, Kinnett, Denger, Martin, Coulter, Booth & 
Khodyakov 
 
Patient and caregiver engagement in CPG development 
 
486 
do. So hearing it from some of the patients was very interesting for me and I learned some 
information. But I think overall, it was a good experience” (Caregiver B10). 
 
• “I learned stuff that I didn’t really think about before and I learned about some treatment things 
that I didn’t really know about before” (Individual with DMD A14). 
 
• “ExpertLens™ gave individuals an opportunity to see where you are, in terms of other parents 
and patients, and what things they are discussing that you may not be thinking about” (Caregiver 
A1). 
 
• “I really did appreciate what other people were writing about, and I learned a lot by just reading 
the other responses” (Caregiver B2).    
Partial Anonymity of the 
ExpertLens™ process 
• “I like the ability to not put a face or a name on the person, just a number.  And that way if there 
was major disagreement, you could still speak your mind” (Caregiver B3). 
 
• “It’s easier to be honest about your own experiences. Like you can just feel a little bit more 
freedom to express yourself maybe where you wouldn’t otherwise” (Caregiver A2). 
 
• “I also liked how it said whether it was a caregiver or a patient with DMD. So it kind of gave me 
a better understanding of how their opinion was. Because I know that adults and individuals with 
DMD, sometimes we see things more important than maybe what parents might and parents 
might think the opposite of certain things” (Individual with DMD B12). 
 
• “That was helpful to know that it was completely anonymous and I feel if you didn’t know that, 
it might change how I would respond to comments. It reinforced, in my mind, that not only do I 
have to think about my perspective as a patient but of the caregiver perspective, as well” 
(Individual with DMD A1). 
 
Convenient Way of Participating in 
Research 
• “You could log on at any time when it’s convenient for you and based on your own personal 
schedule and you could do it. So I mean, that makes it easy. I’m sure if you said, “Okay, this is 
the times we’re doing it,” a lot of people wouldn’t be able to do it at all during those times. So, I 
think just being able to get on when you can and know, okay, I have this amount of time to get it 
done, is good” (Caregiver B24). 
 
• “Yes, actually as I said, online discussion board is very convenient for those like I am a caregiver 
of DMD kid. So I am kind of busy every time, but I am interested in this kind of survey which is 
related to Duchenne Muscular Dystrophy. So, it is very beneficial for me to do this online survey 
as I can post my comments, I can participate in this survey at my own pace, at my own 
convenience of time” (Caregiver A2). 
 
• “I think it’s just a more convenient way of doing it, considering that most people find it difficult 
to get out of the house, I guess.  It was more convenient for me, instead of going somewhere, I 
guess” (Individual with DMD A2). 
 
• “[ExpertLens™] is set up nicely so that I can come in and do one of the modules at a time. I 
knew I could start one and get through maybe one of them and then come back at a later time to 
tackle each of the other ones, in turn” (Individual with DMD B1). 
3. SATISFACTION WITH THE RPM 
Panels Included Both Caregivers 
and Individuals with DMD 
• “It was more the patients themselves, like the older patients. So just understanding from their 
perspective things they’ve been through or how they see and feel things is definitely more 
important. That’s not always what you get as a caregiver. You think about what you want for the 
person that you’re taking care of and so, yeah” (Caregiver A44). 
 
• “As caregivers, I felt like we were either on the same page or totally in different parameters, just 
kind of nowhere near each other. But when I was reading the actual patient - because then it 
makes me think, “Okay, well I’ve got to think about it from my sons’ perspective, if they were 
going through this, would they want to do this or not?” Instead of just assuming you have to do 
everything because I want you to do it versus quality of life for them and their input in making 
those decisions, which is equally as important if not more so” (Caregiver B24). 
 
• “I think it was helpful to get you out of just thinking about what’s valued by the patient, 
because…for certain parts of our lives, our families are heavily involved in care and making 
decisions based on recommendations. Or a recommendation that might be appropriate for one 
might not be appropriate for the other” (Individual with DMD A1). 
 





• “It was definitely very helpful to hear what the patient is feeling rather than what I feel as a 
parent, which is pretty helpful because I want to do what’s important for my son even though 
he’s not old enough right now” (Caregiver B1). 
 
• “…My parents absolutely want the best for me, it’s just they don’t necessarily exactly understand 
how I feel” (Individual with DMD A3). 
 
Individuals with DMD Serve as the 
Experts 
• “There’s a lot of things that [caregivers] aren’t being prepared for, so I thought I was able to tell 
them that certain things may not be as easy as people might think” (Individual with DMD A2). 
 
• “It was more the patients themselves, like the older patients. So just understanding from their 
perspective things they’ve been through or how they see and feel things is definitely more 
important” (Caregiver A44). 
 
• “The individual with Duchenne, I definitely weighed their opinions more than I weighed the 
caregivers. Because they’re the ones living through it. So they’re the ones - but especially as 
adults, my children are younger - so as adults I like to hear their perspective on the care that they 
received” (Caregiver B31). 
Learning New Information and 
New Perspectives 
• “The hope is that you learned something from reading other people's comments or at the least 
gives you a point of view into somebody else's world of possibility. And that may not benefit you 
immediately, but at least in the future you can keep that in the back of your mind” (Caregiver 
B5). 
 
• “Right definitely and I think having that ability to compare responses with other people, like 
you’re also learning a lot from different perspectives” (Caregiver A42). 
 
• “I learned stuff that I didn’t really think about before and I learned about some treatment things 
that I didn’t really know about before” (Individual with DMD A14). 
 
• “But it is good to hear from the families too and to really use the system just for the support or 
it’s just very educational, informative and it was easy-to-use” (Caregiver A29). 
Opportunity to Change Original 
Responses 
• “I found this study to be methodologically more robust, in the sense that it wasn’t just asking 
your responses once. There was opportunity for feedback from the other participants and then 
finally, the third phase, they ask you to repeat the scoring and providing the rationale for why 
one chose the score that they chose to give each of the individual items” (Individual with DMD 
A1). 
 
• “I actually did like revising my answers. After reading everyone’s situations and their different 
opinions, I learned more about [different topics], so I was able to tweak my answers because it 
made me feel differently” (Caregiver B6). 
 
• “… But for some, it was a big deal because they are non-ambulatory and that makes a big 
difference when your peers are all towering over you when you’re standing, as opposed to when 
you’re sitting. So those kinds of answers, I did change a little because it was quite clear a lot of 
people thought that was important” (Caregiver B6).  
 
• “[Although we] were exposed to a new way of thinking [as a result of participating in Round 2], 
the answers never really changed that much” (Individual with DMD A2). 
 
• “I liked the fact that we shared answers with others and we were able to go back, re-evaluate and 
see what others thought and then revisit your answer. So, although I pretty much stayed the same 
on my answer, I did reevaluate and assess it” (Caregiver B7). 
4. PERCEIVED USEFULNESS AND IMPACT OF THE RPM 
Forum for DMD Families  • “[ExpertLens™ is] super important, especially with muscular dystrophy, just because we really 
don’t know a ton about it” (Caregiver A8). 
 
• “What made it easy for me, knowing that it’s the same kind of people those were responding. 
They’re going through the same thing what I’m going through. It’s not somebody…it wasn’t 
really somebody who hasn’t experienced what we are going through. So that makes it feel like a 
community. So the more closer community that you have, the more likely that you’re going to 
open up to talk about everything. So, ExpertLens™ what I felt, it gave a sense of a community” 
(Caregiver A21). 
 
• “It was good information and good to kind of know what other—because we’re all over the 
country and it’s a rare disease. So as much as we want to connect with each other, I think it’s 
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really hard, because we’re trying to take care of our kids and work and do whatever we have to 
do. So it’s hard sometimes to kind of get together” (Caregiver B24). 
 
• “And in general, our Duchenne community is pretty accepting of all the parents. We talk 
anyway, so it’s pretty good. We’ve been pretty supportive of each other anyway. So I feel like in 
general, we’re in a supportive community. So our answers, regardless if our name is on them or 
not, are pretty much everyone’s going to react the same for the most part. So, I just felt 
comfortable pretty much answering mostly anything with this disease” (Caregiver B44). 
ExpertLens™ Provided a Format 
for Incorporating the Patient and 
Caregiver Voice 
• “It’s really important to engage patients and their caregiver. I believe that only they have the 
firsthand experience and they can share their important insight. Because they are dealing with 
everyday life, they are facing challenges and they are creative. They are so creative that they are 
finding solutions to how to overcome the challenges” (Caregiver A9). 
 
• “I think [ExpertLens™] is really, really important because a lot of time the perspective and 
opinions of the caregivers, and especially patients, are not taken into account”  (Individual with 
DMD B6). 
 
• “I think [ExpertLens™ is] really good because sometimes if the physicians and the medical team 
are not dealing with things every day, they don’t quite understand what is more important or less 
important to the patients and sometimes I think they have unrealistic goals and even treatments 
sometimes. And I think it’s good that they hear from the caregivers” (Caregiver B31). 
Empowered Patients and 
Caregivers 
• “It brought up questions that I didn’t even know to ask. It brought up topics that I wasn’t aware 
of. It empowered me. It gave me a little bit of a say in what’s going on. It made me feel better 
that the parents’ perspective is being taken and that they’re looking into these different areas, 
which is kind of cool” (Caregiver B10). 
 
• “[ExpertLens™] was really helpful to me in my next appointment because of the age that my 
kids are at. So certain things like puberty and all of that that were discussed and a lot of it was, 
“Well okay it’s really up to you guys” (Caregiver A42). 
Doctors Could Benefit from Patient 
and Caregiver Input to Support 
Current Standards and 
Recommendations  
• “Once the guidelines are developed this way, they’re going to be pretty useful for clinicians. It 
will really help them understand what really matters most and is important for the community” 
(Caregiver A1). 
 
• “I know the doctors get involved in the guidelines, but…they don’t see it day in and day out. I 
think it’s very important for the caregivers and the patients to have output and input on what the 
guidelines should be” (Caregiver B44). 
 
• “Some doctors are not introduced to Duchenne with the information and some of them, like my 
son was introduced at the age of nine - not fully, but some.  It's important for them because I feel 
that clinicians still have trouble understanding that not all patients that are diagnosed with 
Duchenne will follow the same paths and will have the same way of thinking.  So it's good to 
have a multitude amount of information so that they can gauge the individual that they're treating 
with a more caring approach” (Caregiver B19). 
 
• “Even though doctors are experts in it, they still maybe don’t understand exactly what people go 
through. So it’s good to have somebody who’s experienced to tell you what they’ve done” 
(Individual with DMD A4). 
5. CHALLENGES WITH THE EXPERTLENS™ PROCESS AND SUGGESTIONS FOR IMPROVEMING THE RPM  
Show Not Only Round 1 Responses 
to Rating Questions, but also 
Rationale Comments 
• “It was difficult to determine what my initial [rationale] response was. I think it would have been 
better if I could have somehow seen what all my answers were in that category [of rationale 
comments] in Round 1” (Caregiver B06). 
 
• “So sometimes I don’t know if my answer was different because I was having difficulty finding 
what I originally said. Like it wouldn’t come up right in the box like, “This is what you said and 
this is what you rated.” I kind of had to scroll through the comments”  (Caregiver B10). 
 
• “Most of it.  The only thing I would have hoped was on there is that instead of going back to find 
my answer, that it would have your rating in your answer right there” (Individual with DMD A4) 
Need More Clarity in the 
Instructions 
• “The instructions weren’t exactly clear as to whether you have to respond to each one, just a few, 
or the ones you disliked or liked” (Caregiver B04). 
 
• “I guess just separate it out a little bit more, just step-by-step instead of here’s all the instructions 
and then you’re kind of thrown into it with a whole lot to do, maybe one thing at a time” 
(Caregiver A44). 
 





• “And I think it can be simplified. Compared to the other ones, the way they're set up, I think 
[ExpertLens™] needs some work with the way it's orientated and explained to the people that are 
participating” (Caregiver B19). 
Improve Email Digests • “Visually, I had to really focus to make sure I finished the page and that I clicked on each thing 
to make sure I could see all the responses” (Caregiver B11). 
 
• “Eventually I figured it out, but I would have liked it to be a little better organized so that you 
could see what people’s responses are and how the threads were organized” (Caregiver B12). 
 
• “I like your reminders but the digests, I mean I wish I could have gotten it less often. If I would 
have gotten a daily reminder that said, “Hey, don’t forget if you’ve got time, come in, answer 
more, add to it,” but when other people answered, I guess it didn’t really impact me because I 
wasn’t—like I said, we were super busy. I wasn’t going to take extra time right that second, but I 
knew that later I was going to anyway. And every time I would log in, I would just go back over 
everything anyways” (Caregiver A42). 
 
• “The digests saying where there’s new comments and stuff, to me that wasn’t really helpful 
because it was hard to tell specifically where the new comments were and stuff. Like I feel like if 
it would be possible to make it more apparent where there’s new conversation taking place” 
(Individual with DMD A2). 
Decrease Participation Burden • “It would be interesting if for the survey, you picked just one topic like either weight or height. 
Then, on days one and two, you put your comments in. On days three and four, you read through 
[the comments], and then on days five and six, you responded. If you were just focused on one 
topic, you can think about it a little bit more and focus in on it” (Caregiver A10). 
 
• “It was exhausting the complexity of the question that followed with another question that 
seemed going back to the first question.  So to me that’s what wore me out was just almost 
hearing the same question but you wanted to know from a different perspective and from this 
perspective which I think is just, again, how some of the questions were reworded and that was 
kind of exhaustive” (Caregiver B19). 
 
• “It was exhausting the complexity of the question that followed with another question that 
seemed going back to the first question.  So to me that’s what wore me out was just almost 
hearing the same question but you wanted to know from a different perspective and from this 
perspective which I think is just, again, how some of the questions were reworded and that was 
kind of exhaustive” (Caregiver B3) 
 
 
 
 
 
 
 
 
 
 
